Benign Prostate Hyperplasia (BPH) Treatment Market to be Dominated by Surgical Treatment through 2028
Increasing prevalence of benign prostate hyperplasia and
product launches along with government approvals is expected to drive the
growth of Global of Benign Prostate Hyperplasia Treatment Market during the
forecast period.
According to TechSci Research
report, “Benign Prostate Hyperplasia (BPH) Treatment Market - Global Industry Size,
Share, Trends, Competition, Opportunity, and Forecast, 2018-2028,” the Global benign prostate hyperplasia Treatment market will
register an impressive CAGR in the forecast period, 2023-2028 on account of
increasing incidences hormonal imbalance and aging population.
BPH Treatment incorporates
minimally invasive techniques. As the prostate enlarges, it presses against the
urethra. So, the bladder wall becomes thicker and weak, ultimately losing the
ability to release, leading to urine retention. According to the name, BPH is
benign and non-cancerous. However, aging and family history increase a man’s
risk of suffering from BPH.
However, stringent
regulatory scenario related to the lack of awareness regarding various
urological diseases is likely to slow down the market growth in the coming
years. Also, lack of skilled medical professionals to conduct minimally
invasive surgeries pertaining to BPH Treatment especially in the emerging
countries can further slowdown the market growth.
Browse over XX market
data Figures spread through XX Pages and an in-depth TOC on "Global Benign Prostate Hyperplasia (BPH) Treatment Market"
Global
BPH Treatment Market can be segmented into drug treatment, surgical treatment, end
user, region, and company.
In
terms of drug treatment, the market can be segmented into alpha blockers, 5-alpha
reductase inhibitors, and phosphodiesterase-5 inhibitors. The phosphodiesterase-5
inhibitors segment is expected to show an impressive growth during the forecast
period due to their efficacy.
Based
on the surgical treatment the market can be classified into transurethral
resection of the prostate (TURP), prostatic urethral lift (PUL), prostatectomy,
laser surgery, transurethral microwave technique (TUMT), transurethral needle
ablation of the prostate (TUNA), and others. The transurethral resection of the
prostate (TURP) segment is expected to dominate the market through 2028 due to
increasing demand for minimally invasive procedures and government health
insurance policies.
Based
on the end user the market can be segmented into hospitals & clinics, ambulatory
surgical centers, and others. The hospital & clinics segment dominates the
market and is likely to remain dominant in the forecast years owing to increase
advancement in healthcare facilities and government policies to boost the
treatments. Moreover, hospital are more convenient as compared to ambulatory
surgical centers which in turn drivers the growth of the market . Hence, propelling
the growth of Global BPH Treatment market.
The
leading companies operating in the Global BPH Treatment Market are:
- Boston Scientific Corporation
- Coloplast
Corporation
- Teleflex
Incorporated
- Olympus Corporation
- Glaxo Smith Kline
PLC
- Eli Lily
- Abbott Laboratories
- Medifocus Inc.
- Urologix, LLC
- Pfizer Inc.
Download Free Sample Report
Customers
can also request for 10% free customization on this report.
“The prevalence of the BPH is
rising, which is encouraging the use of cutting-edge therapies including laser
therapy, prostatic stenting, and UroLift therapy and propelling the growth of
the sector in the area. The advancement of the players in the region over the
coming few years will also be supported by attractive reimbursement rules and
an increase in the number of qualified surgeons. There are a number of device
and pharmaceutical businesses in the area, and they are all keenly interested
in undertaking R&D operations and developing new products to improve the
standard of care. Furthermore, laser therapy is widely used due to the
availability of cutting-edge medical infrastructure. Modern laser equipment is
available in many clinics and urology centres to treat BPH, which advances the
area.”, said Mr. Karan Chechi, Research Director with TechSci Research, a
research based global management consulting firm.
“BPH
Treatment Market - Global Industry Size, Share, Trends, Competition,
Opportunity, and Forecast, 2018-2028, Segmented By Drug Treatment (Alpha
Blockers, 5-Alpha Reductase Inhibitors, and phosphodiesterase-5 inhibitors), By
Surgical Treatment (Transurethral resection of the prostate (TURP), Prostatic
Urethral Lift (PUL), Prostatectomy, Laser Surgery, Transurethral Microwave Technique
(TUMT), Transurethral Needle Ablation of the Prostate (TUNA), and Others), By
End User (Hospitals & Clinics, , Ambulatory
Surgical Centers, and Others), By Region,” has evaluated the future growth potential
of Global BPH Treatment Market and provides statistics & information on
market size, structure, and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Global BPH
Treatment Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com